BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ciupe SM. Modeling the dynamics of hepatitis B infection, immunity, and drug therapy. Immunol Rev 2018;285:38-54. [PMID: 30129194 DOI: 10.1111/imr.12686] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Churkin A, Kriss S, Uziel A, Goyal A, Zakh R, Cotler SJ, Etzion O, Shlomai A, Rotstein HG, Dahari H, Barash D. Machine learning for mathematical models of HCV kinetics during antiviral therapy. Math Biosci 2021;343:108756. [PMID: 34883104 DOI: 10.1016/j.mbs.2021.108756] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
2 Viriyapong R, Ridbamroong W. Global stability analysis and optimal control of measles model with vaccination and treatment. J Appl Math Comput 2020;62:207-37. [DOI: 10.1007/s12190-019-01282-x] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
3 Perelson AS, Ribeiro RM. Introduction to modeling viral infections and immunity. Immunol Rev 2018;285:5-8. [PMID: 30129196 DOI: 10.1111/imr.12700] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
4 Gonçalves A, Lemenuel-Diot A, Guedj J. Reply to: 'Early HBV RNA kinetics under NA treatment may reveal new insights into HBV RNA dynamics and NA mode of action'. J Viral Hepat 2021;28:689-90. [PMID: 33462946 DOI: 10.1111/jvh.13470] [Reference Citation Analysis]
5 Chen C, Liu Y, Wang H, Chen G, Wu X, Ren J, Zhang H, Zhao Y. Multifunctional Chitosan Inverse Opal Particles for Wound Healing. ACS Nano 2018;12:10493-500. [PMID: 30256608 DOI: 10.1021/acsnano.8b06237] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 20.5] [Reference Citation Analysis]
6 Akpinar MY, Simsek GG, Aksoy EK, Sapmaz FP, Kantarci S, Uzman M, Nazligul Y. Survivin expression starts before hepatocellular cancer development in the liver of chronic hepatitis B patients: a pilot, cross-sectional study. Prz Gastroenterol 2020;15:138-43. [PMID: 32550946 DOI: 10.5114/pg.2019.87081] [Reference Citation Analysis]
7 Churkin A, Lewkiewicz S, Reinharz V, Dahari H, Barash D. Efficient Methods for Parameter Estimation of Ordinary and Partial Differential Equation Models of Viral Hepatitis Kinetics. Mathematics (Basel) 2020;8:1483. [PMID: 33224865 DOI: 10.3390/math8091483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Gonçalves A, Mentré F, Lemenuel-Diot A, Guedj J. Model Averaging in Viral Dynamic Models. AAPS J 2020;22:48. [PMID: 32060662 DOI: 10.1208/s12248-020-0426-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Tang R, Lei Z, Wang X, Qi Q, He J, Liu D, Wang X, Chen X, Zhu J, Li Y, Zhou S, Su C. Hepatitis B envelope antigen increases Tregs by converting CD4+CD25- T cells into CD4+CD25+Foxp3+ Tregs. Exp Ther Med 2020;20:3679-86. [PMID: 32855720 DOI: 10.3892/etm.2020.9107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Smith AM. Validated Models of Immune Response to Virus Infection. Curr Opin Syst Biol 2018;12:46-52. [PMID: 31723715 DOI: 10.1016/j.coisb.2018.10.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
11 Yosyingyong P, Viriyapong R. Global stability and optimal control for a hepatitis B virus infection model with immune response and drug therapy. J Appl Math Comput 2019;60:537-65. [DOI: 10.1007/s12190-018-01226-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
12 Ferrari Gianlupi J, Mapder T, Sego TJ, Sluka JP, Quinney SK, Craig M, Stratford RE, Glazier JA. Multiscale Model of Antiviral Timing, Potency, and Heterogeneity Effects on an Epithelial Tissue Patch Infected by SARS-CoV-2. Viruses 2022;14:605. [DOI: 10.3390/v14030605] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Ciupe SM, Vaidya NK, Forde JE. Early events in hepatitis B infection: the role of inoculum dose. Proc Biol Sci 2021;288:20202715. [PMID: 33563115 DOI: 10.1098/rspb.2020.2715] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Heitzman-Breen N, Golden J, Vazquez A, Kuchinsky SC, Duggal NK, Ciupe SM. Modeling the dynamics of Usutu virus infection in birds. J Theor Biol 2021;531:110896. [PMID: 34506809 DOI: 10.1016/j.jtbi.2021.110896] [Reference Citation Analysis]
15 Jenner AL, Aogo RA, Davis CL, Smith AM, Craig M. Leveraging Computational Modeling to Understand Infectious Diseases. Curr Pathobiol Rep 2020;:1-13. [PMID: 32989410 DOI: 10.1007/s40139-020-00213-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
16 Kadelka S, Dahari H, Ciupe SM. Understanding the antiviral effects of RNAi-based therapy in HBeAg-positive chronic hepatitis B infection. Sci Rep 2021;11:200. [PMID: 33420293 DOI: 10.1038/s41598-020-80594-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
17 Jiang X; College of Science, North China University of Technology, Beijing 100144, China. . MATH 2022;7:2456-78. [DOI: 10.3934/math.2022138] [Reference Citation Analysis]